BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.21B
AUM Growth
-$804M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
166
New
Increased
Reduced
Closed

Top Buys

1
+$31.1M
2
+$24.2M
3
+$21.5M
4
HUM icon
Humana
HUM
+$20.8M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$10.5M

Top Sells

1
+$60.3M
2
+$56.9M
3
+$32.8M
4
CRL icon
Charles River Laboratories
CRL
+$16.7M
5
TMO icon
Thermo Fisher Scientific
TMO
+$15M

Sector Composition

1 Healthcare 99.13%
2 Industrials 0.77%
3 Energy 0.04%
4 Communication Services 0.01%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
$1.09M 0.02%
37,100
127
$1.05M 0.02%
44,500
128
$1.03M 0.02%
+19,850
129
$978K 0.02%
63,770
+19,370
130
$895K 0.01%
48,800
131
$888K 0.01%
33,000
132
$851K 0.01%
24,500
133
$851K 0.01%
+12,500
134
$847K 0.01%
+16,800
135
$816K 0.01%
23,900
136
$791K 0.01%
6,000
137
$788K 0.01%
39,200
+14,200
138
$710K 0.01%
4,763
-1,411
139
$605K 0.01%
39,200
-26,000
140
$577K 0.01%
3,900
141
$500K 0.01%
+30,000
142
$317K 0.01%
+9,555
143
$273K ﹤0.01%
123,426
-12,707
144
$177K ﹤0.01%
4,100
145
$161K ﹤0.01%
1,324
-618
146
$161K ﹤0.01%
5,000
147
$109K ﹤0.01%
38,000
-107,646
148
$46.1K ﹤0.01%
700
+31
149
$29.1K ﹤0.01%
40
150
$27.5K ﹤0.01%
739
3 4 5
6
7